Preterm Feeding Maturity Measurement and Evaluation
One of 2,265 projects Taiyo tracks in Türkiye.
Source: EU Funding & Tenders Portal
PREMADES is a medical diagnostic device, developed to provide health care practitioners an objective yet noninvasive means for the assessment of feeding maturity, by analyzing the swallowing patterns acquired using sensors placed around their hyoid regions. It is also intended to monitor the improvements by regular measurements and analysis of feeding maturity in the preterm infants and compare pa
- Status
- Closed
- Sector
- Hospital
- Location
- Turkey
- Updated
- 22 Jul 2026
- Source
- EU Funding & Tenders Portal
ConstructChat
Ask ConstructChat about Preterm Feeding Maturity Measurement and Evaluation
Pick a question to edit it, or write your own.
First answer free · no account
Project Information FAQ
Project Information
Participants
| Not available for this record. |
Status
Original status | ended |
Taiyo status | Closed |
Taiyo last update | 2026-07-22 |
Contact
| Not available for this record. |
Description
Description | PREMADES is a medical diagnostic device, developed to provide health care practitioners an objective yet noninvasive means for the assessment of feeding maturity, by analyzing the swallowing patterns acquired using sensors placed around their hyoid regions. It is also intended to monitor the improvements by regular measurements and analysis of feeding maturity in the preterm infants and compare past evaluations. This non-invasive design will be painless for infants and user friendly for the medical staff. Currently, in practice, doctors utilize observational, trial-and-error techniques or nursing assessment for identification of feeding skills in preterm infants, which are mostly subjective. Efforts aimed at more objective assessment techniques have focused on invasive, pressure measurement methods that can be particularly painful for infants. However, such methods are not well suited for regular and real-time monitoring of feeding maturity, thus are not preferred in practice. As a H2020 SME Phase-1 beneficiary, an intensive feasibility study, including market, profitability analyses, possible improvements required for the prototype and a work plan has been successfully prepared. PREMADES, will meet a highly important need, particularly in the neonatal medicine. The product is expected to be proper for point of care usage, marketable globally. Total available market size of our product is €716M/year. According to the results of our detailed financial feasibility study, we are planning to achieve €67M revenue creating a total of 65 new jobs at the end of the fourth year. In Phase-2, further technical improvements will be made on the prototype and intensive commercialization activities will be implemented. To ensure a successful entrance and fast penetration into the European markets, the outcomes of the Phase 1 studies will be carefully used in Phase 2, which will help in terms of the design, production and marketing procedures to be conducted in a right manner. |
Location
Country | Turkey |
Source
Source | EU Funding & Tenders Portal |
URL |
More Details
Record type | Project |
Sector | Hospital |
Article published date | 2026-01-15 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this project
- News and media coverage
- Technical research
Free account · no card · lands you back on this project
